SOTAC — Sotac Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹1.89bn
- IN₹1.90bn
- IN₹579.83m
- 47
- 14
- 79
- 42
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 5.86 | 4.37 | 0.276 | 96 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 73.5 | 60.5 | 149 | 115 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 137 | 173 | 259 | 366 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 160 | 166 | 87.9 | 141 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 304 | 347 | 353 | 548 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 193 | 228 | 276 | 271 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 273 | 322 | 286 | 433 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 30.6 | 24.9 | 66.2 | 115 |
Total Liabilities & Shareholders' Equity | 304 | 347 | 353 | 548 |
Total Common Shares Outstanding |